tiprankstipranks

Jason Cole Insider Profile

4 Followers
Jason Cole, Chief Strategy & Financial Off at Bluebird Bio, holds 189.55K shares in Bluebird Bio (Ticker: BLUE), holds 15.09K shares in Epirus Biopharma (Ticker: EPRSQ). Most recently, Jason Cole Sold ― shares of Bluebird Bio on Aug 23, 2022 for an estimated value of 78.35K.
tipranks
Jason Cole

Jason Cole
Bluebird Bio (BLUE)
Chief Strategy & Financial Off

Ranked #380 out of 98,501 Corporate Insiders

Profitable Transactions

80%
20 out of 25 Profitable Transactions

Average Return

+42.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$195K
96.14%
3.86%
A breakdown of Jason Cole's holdings

Insider Roles

Bluebird Bio
(BLUE)
Chief Strategy & Financial Off
Epirus Biopharma
(EPRSQ)
EVP,Corp Dev & General Counsel
Roles that Jason Cole holds in companies

Most Profitable Insider Trade

Stock:
Bluebird Bio
(BLUE)
Rating:Informative Buy
Date:Apr 28, 2017 - Apr 28, 2018
Return:+90.50%
The most profitable trade made by Jason Cole

Jason Cole's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Bluebird Bio
Aug 23, 2022
Chief Strategy & Financial Off
Informative Sell
78.35K
$187.65K
Epirus Biopharma
Jan 31, 2012
EVP,Corp Dev & General Counsel
Uninformative Sell
2.64K
$7.54K
List of latest transactions for each holding click on a transaction to see Jason Cole's performance on stock

Jason Cole insider profile FAQ

What is the percentage of profitable transactions made by Jason Cole?
The percentage of profitable transactions made by Jason Cole is 80%.
    What is the average return per transaction made by Jason Cole?
    The average return per transaction made by Jason Cole is 42.20%.
      What stocks does Jason Cole hold?
      Jason Cole holds: BLUE, EPRSQ stocks.
        What was Jason Cole’s latest transaction?
        Jason Cole latest transaction was an Informative Sell of $78.35K.
          What was Jason Cole's most profitable transaction?
          Jason Cole’s most profitable transaction was an Informative Buy of BLUE stock on April 28, 2017. The return on the trade was 90.50%.
            What is Jason Cole's role in Bluebird Bio?
            Jason Cole's role in Bluebird Bio is Chief Strategy & Financial Off.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.